SCHOTT Pharma AG & Co. KGaA Income Statement

Financials in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Revenue	957.09	957.09	898.6	821.14	648.67	584.23
Revenue Growth (YoY)	6.51%	6.51%	9.43%	26.59%	11.03%	-
Cost of Revenue	634.48	634.48	582.11	524.51	422.5	388.22
Gross Profit	322.61	322.61	316.49	296.64	226.17	196.01
Selling, General & Admin	125.18	125.18	122.68	110.78	92.5	89.63
Research & Development	24.25	24.25	26.82	23.53	22.29	23.58
Other Operating Expenses	-15.67	-15.67	-4.23	-5.68	-3.12	-8.18
Operating Expenses	133.77	133.77	145.28	128.63	111.67	105.04
Operating Income	188.84	188.84	171.21	168.01	114.5	90.97
Interest Expense	-12.78	-12.78	-6.66	-2.11	-1.19	-1.51
Interest & Investment Income	5.96	5.96	5.23	2.14	0.56	0.56
Earnings From Equity Investments	12.49	12.49	11.74	12.99	13.7	5.55
Currency Exchange Gain (Loss)	-11.09	-11.09	2.71	-7.03	-1.45	0.45
Other Non Operating Income (Expenses)	-1.08	-1.08	-4.55	-5.54	-3.26	-1.55
EBT Excluding Unusual Items	182.35	182.35	179.68	168.46	122.87	94.46
Merger & Restructuring Charges	-	-	-	-11.78	-	-
Gain (Loss) on Sale of Assets	0.59	0.59	0.39	1.51	0.3	0.72
Asset Writedown	-	-	5.2	-	-	-
Pretax Income	183.97	183.97	185.8	158.29	123.28	95.3
Income Tax Expense	33.63	33.63	33.87	32.44	22.12	17.67
Earnings From Continuing Operations	150.35	150.35	151.93	125.85	101.17	77.63
Minority Interest in Earnings	-0.66	-0.66	-0.09	-0.47	-0.41	-0.15
Net Income	149.69	149.69	151.84	125.38	100.75	77.48
Net Income to Common	149.69	149.69	151.84	125.38	100.75	77.48
Net Income Growth	-1.42%	-1.42%	21.11%	24.44%	30.04%	-
Shares Outstanding (Basic)	151	151	151	151	151	151
Shares Outstanding (Diluted)	151	151	151	151	151	151
Shares Change (YoY)	-	-	-	0.00%	-	-
EPS (Basic)	0.99	0.99	1.01	0.83	0.67	0.51
EPS (Diluted)	0.99	0.99	1.01	0.83	0.67	0.51
EPS Growth	-1.80%	-1.80%	21.46%	24.08%	31.17%	-
Free Cash Flow	80.25	80.25	6.19	30.11	34.14	19.22
Free Cash Flow Per Share	0.53	0.53	0.04	0.20	0.23	0.13
Dividend Per Share	0.160	0.160	0.150	0.125	-	-
Dividend Growth	6.67%	6.67%	20.00%	-	-	-
Gross Margin	33.71%	33.71%	35.22%	36.13%	34.87%	33.55%
Operating Margin	19.73%	19.73%	19.05%	20.46%	17.65%	15.57%
Profit Margin	15.64%	15.64%	16.90%	15.27%	15.53%	13.26%
Free Cash Flow Margin	8.38%	8.38%	0.69%	3.67%	5.26%	3.29%
EBITDA	249	249	217.5	211.8	150.94	124.7
EBITDA Margin	26.02%	26.02%	24.20%	25.79%	23.27%	21.34%
D&A For EBITDA	60.16	60.16	46.29	43.79	36.44	33.73
EBIT	188.84	188.84	171.21	168.01	114.5	90.97
EBIT Margin	19.73%	19.73%	19.05%	20.46%	17.65%	15.57%
Effective Tax Rate	18.28%	18.28%	18.23%	20.49%	17.94%	18.54%

Source: S&P Capital IQ. Standard template. Financial Sources.